You are here

Novan

Second-quarter catalysts for the smaller players

EP Vantage

Wed, 04/7/21 - 10:25 am

Fulcrum Therapeutics

Gemini Therapeutics

Novan crushed by phase 3 failures of antiviral gel

Fierce Biotech

Fri, 01/3/20 - 10:10 am

molluscum contagiosum

Ligand acquires milestone and royalty rights to SB206 from Novan

Pharmaceutical Business Review

Tue, 05/7/19 - 10:05 am

Ligand Pharmaceuticals

skin infections

Novan spikes on positive antifungal results

BioPharma Dive

Thu, 04/13/17 - 09:41 am

Novan’s Topical Treatment Shows Efficacy Against Drug-resistant Bugs

Drug Discovery and Development

Thu, 08/21/14 - 08:19 am

antibiotic resistance